Spots Global Cancer Trial Database for recurrent childhood brain tumor
Every month we try and update this database with for recurrent childhood brain tumor cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Photodynamic Therapy With Porfimer Sodium in Treating Patients With Refractory Brain Tumors | NCT00002647 | Brain and Centr... Metastatic Canc... | verteporfin conventional su... | 3 Years - 70 Years | National Cancer Institute (NCI) | |
| Immunotoxin Therapy in Treating Children With Recurrent Malignant Gliomas | NCT00053040 | Brain and Centr... | cintredekin bes... conventional su... | 3 Years - 21 Years | Pediatric Brain Tumor Consortium | |
| Vaccine Therapy and Sargramostim in Treating Patients With Sarcoma or Brain Tumor | NCT00069940 | Brain and Centr... Gastrointestina... Sarcoma | sargramostim telomerase: 540... | 2 Years - | Dana-Farber Cancer Institute | |
| Ex Vivo Drug Sensitivity Testing and Mutation Profiling | NCT03860376 | Recurrent Child... Recurrent Child... Recurrent Child... Refractory Chil... Refractory Chil... Refractory Chil... Recurrent Child... Recurrent Child... Recurrent Child... Recurrent Child... Recurrent Child... Recurrent Child... Recurrent Child... Refractory Chro... | 1 Day - 21 Years | Florida International University | ||
| Monoclonal Antibody Therapy in Treating Patients With Recurrent Gliomas | NCT00002753 | Brain and Centr... | iodine I 131 mo... | 3 Years - | Duke University | |
| Combination Chemotherapy and Tamoxifen in Treating Patients With Solid Tumors | NCT00002608 | Adrenocortical ... Brain and Centr... Head and Neck C... Liver Cancer Malignant Mesot... Pheochromocytom... Sarcoma | cisplatin doxorubicin hyd... tamoxifen citra... conventional su... radiation thera... | - 65 Years | National Cancer Institute (NCI) | |
| Combination Chemotherapy Followed by Bone Marrow and/or Peripheral Stem Cell Transplantation in Treating Patients With Recurrent Medulloblastoma or CNS Germ Cell Tumors | NCT00002594 | Brain Tumor Central Nervous... | Sargramostim cyclophosphamid... melphalan autologous bone... bone marrow abl... peripheral bloo... | 2 Years - 25 Years | Children's Oncology Group | |
| Selecting Patient-Specific Biologically Targeted Therapy for Pediatric Patients With Refractory Or Recurrent Brain Tumors | NCT02015728 | Recurrent Child... | Tumor biology t... Temozolomide Etoposide Sorafenib Everolimus Erlotinib Dasatinib | 1 Month - 30 Years | Seattle Children's Hospital | |
| Erlotinib Alone or in Combination With Radiation Therapy in Treating Young Patients With Refractory or Relapsed Malignant Brain Tumors or Newly Diagnosed Brain Stem Glioma | NCT00360854 | Brain and Centr... | erlotinib hydro... mutation analys... polymorphism an... laboratory biom... pharmacological... radiation thera... | 1 Year - 21 Years | National Cancer Institute (NCI) | |
| Gallium Nitrate in Treating Children With Brain Tumor, Neuroblastoma, Rhabdomyosarcoma, Non-Hodgkin's Lymphoma, or Refractory Solid Tumors | NCT00002543 | Brain and Centr... Lymphoma Neuroblastoma Sarcoma Unspecified Chi... | gallium nitrate | - 21 Years | National Cancer Institute (NCI) | |
| TP-38 Toxin in Treating Young Patients With Recurrent or Progressive Supratentorial High-Grade Glioma | NCT00074334 | Brain and Centr... | TGFa-PE38 immun... conventional su... | 3 Years - 21 Years | Pediatric Brain Tumor Consortium | |
| Ispinesib in Treating Young Patients With Relapsed or Refractory Solid Tumors or Lymphoma | NCT00363272 | Childhood Burki... Childhood Centr... Childhood Choro... Childhood Crani... Childhood Grade... Childhood Grade... Childhood Grade... Childhood High-... Childhood Infra... Childhood Low-g... Childhood Spina... Childhood Supra... Recurrent Child... Recurrent Child... Recurrent Child... Recurrent Child... Recurrent Child... Recurrent Child... Recurrent Child... Recurrent Child... Recurrent Child... Recurrent Child... Recurrent Child... Recurrent Child... Unspecified Chi... | ispinesib laboratory biom... pharmacological... | 1 Year - 21 Years | National Cancer Institute (NCI) | |
| Immunotoxin Therapy in Treating Children With Recurrent Malignant Gliomas | NCT00053040 | Brain and Centr... | cintredekin bes... conventional su... | 3 Years - 21 Years | Pediatric Brain Tumor Consortium | |
| PTC299 in Treating Young Patients With Refractory or Recurrent Primary Central Nervous System Tumors | NCT01158300 | Brain and Centr... | VEGF inhibitor ... | 3 Years - 21 Years | Pediatric Brain Tumor Consortium | |
| Selecting Patient-Specific Biologically Targeted Therapy for Pediatric Patients With Refractory Or Recurrent Brain Tumors | NCT02015728 | Recurrent Child... | Tumor biology t... Temozolomide Etoposide Sorafenib Everolimus Erlotinib Dasatinib | 1 Month - 30 Years | Seattle Children's Hospital | |
| Cyproheptadine in Preventing Weight Loss in Children Receiving Chemotherapy for Cancer | NCT01132547 | Cancer | cyproheptadine ... placebo | 2 Years - 21 Years | University of South Florida | |
| Cisplatin and Temozolomide in Treating Young Patients With Malignant Glioma | NCT00360945 | Brain and Centr... | cisplatin temozolomide fluorescence in... loss of heteroz... immunohistochem... laboratory biom... radiation thera... | 4 Years - 20 Years | National Cancer Institute (NCI) | |
| Cilengitide in Treating Children With Refractory Primary Brain Tumors | NCT00063973 | Childhood Centr... Childhood Choro... Childhood Crani... Childhood Epend... Childhood Grade... Childhood Grade... Childhood Grade... Childhood High-... Childhood High-... Childhood Infra... Childhood Low-g... Childhood Low-g... Childhood Medul... Childhood Mixed... Childhood Oligo... Childhood Supra... Recurrent Child... Recurrent Child... Recurrent Child... Recurrent Child... Recurrent Child... Recurrent Child... Recurrent Child... Recurrent Child... Recurrent Child... Recurrent Child... | cilengitide laboratory biom... | - 21 Years | National Cancer Institute (NCI) | |
| Radiolabeled Monoclonal Antibody Therapy in Treating Patients With Primary or Metastatic Brain Cancers | NCT00002752 | Brain and Centr... Metastatic Canc... | iodine I 131 mo... | 3 Years - | Duke University | |
| Gallium Nitrate in Treating Children With Brain Tumor, Neuroblastoma, Rhabdomyosarcoma, Non-Hodgkin's Lymphoma, or Refractory Solid Tumors | NCT00002543 | Brain and Centr... Lymphoma Neuroblastoma Sarcoma Unspecified Chi... | gallium nitrate | - 21 Years | National Cancer Institute (NCI) | |
| Cilengitide in Treating Younger Patients With Recurrent or Progressive High-Grade Glioma That Has Not Responded to Standard Therapy | NCT00679354 | Childhood High-... Childhood High-... Recurrent Child... Recurrent Child... Recurrent Child... Recurrent Child... Recurrent Child... Recurrent Child... Recurrent Child... Recurrent Child... | cilengitide laboratory biom... pharmacological... | - 21 Years | National Cancer Institute (NCI) | |
| Combination Chemotherapy Followed by Bone Marrow and/or Peripheral Stem Cell Transplantation in Treating Patients With Recurrent Medulloblastoma or CNS Germ Cell Tumors | NCT00002594 | Brain Tumor Central Nervous... | Sargramostim cyclophosphamid... melphalan autologous bone... bone marrow abl... peripheral bloo... | 2 Years - 25 Years | Children's Oncology Group | |
| Vaccine Therapy and Sargramostim in Treating Patients With Sarcoma or Brain Tumor | NCT00069940 | Brain and Centr... Gastrointestina... Sarcoma | sargramostim telomerase: 540... | 2 Years - | Dana-Farber Cancer Institute | |
| Acetylcysteine, Mannitol, Combination Chemotherapy, and Sodium Thiosulfate in Treating Children With Malignant Brain Tumors | NCT00238173 | Bone Marrow Sup... Brain and Centr... Drug/Agent Toxi... Long-term Effec... | filgrastim acetylcysteine carboplatin cyclophosphamid... etoposide phosp... mannitol sodium thiosulf... | 1 Year - 18 Years | OHSU Knight Cancer Institute | |
| Cilengitide in Treating Younger Patients With Recurrent or Progressive High-Grade Glioma That Has Not Responded to Standard Therapy | NCT00679354 | Childhood High-... Childhood High-... Recurrent Child... Recurrent Child... Recurrent Child... Recurrent Child... Recurrent Child... Recurrent Child... Recurrent Child... Recurrent Child... | cilengitide laboratory biom... pharmacological... | - 21 Years | National Cancer Institute (NCI) |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
